UBS Group’s Nutrien NTR Stock Holding History

UBS Group’s Portfolio NTR Stock Details NTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$981K	Buy	+13,000	New	+$927K	﹤0.01%	5574
2025 Q2	–	Sell	-21,500	Closed	-$1.07M	–	10658
2025 Q1	$1.07M	Buy	21,500 +11,500	+115%	+$588K	﹤0.01%	5240
2024 Q4	$448K	Buy	+10,000	New	+$475K	﹤0.01%	5921
2024 Q1	–	Sell	-30,000	Closed	-$1.69M	–	9803
2023 Q4	$1.69M	Hold	30,000	–	–	﹤0.01%	3997
2023 Q3	$1.85M	Hold	30,000	–	–	﹤0.01%	3508
2023 Q2	$1.77M	Buy	+30,000	New	+$1.91M	﹤0.01%	3647
2022 Q4	–	Sell	-107,500	Closed	-$8.96M	–	11008
2022 Q3	$8.96M	Buy	+107,500	New	+$9.25M	﹤0.01%	1883
2021 Q4	–	Sell	-11,040	Closed	-$716K	–	10554
2021 Q3	$716K	Buy	+11,040	New	+$675K	﹤0.01%	4467
2020 Q1	–	Sell	-50,000	Closed	-$2.4M	–	8256
2019 Q4	$2.4M	Buy	50,000 +40,000	+400%	+$1.93M	﹤0.01%	3377
2019 Q3	$499K	Buy	+10,000	New	+$510K	﹤0.01%	4569
2019 Q2	–	Sell	-53,600	Closed	-$2.83M	–	8062
2019 Q1	$2.83M	Buy	+53,600	New	+$2.79M	﹤0.01%	2680
2018 Q2	–	Sell	-35,000	Closed	-$1.65M	–	8164
2018 Q1	$1.65M	Buy	+35,000	New	+$1.75M	﹤0.01%	3289

Other funds holding NTR

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Group's NTR Position: Q1 2026 in Review

UBS Group increased its Nutrien (NTR) stake by 1.4% in Q1 2026, buying an estimated $1.04M and bringing the position to 1,078,557 shares worth $81.4M. The position accounts for 0.01% of the portfolio, ranked #1209.

UBS Group first reported a position in NTR in Q1 2018 and has held it in 33 quarters since. The position peaked at $128M in Q1 2022. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

UBS Group held 1,078,557 shares of Nutrien worth $81.4M as of Q1 2026.
UBS Group bought 14,541 Nutrien shares in Q1 2026, an estimated $1.04M.
Nutrien made up 0.01% of UBS Group's portfolio in Q1 2026, its #1209 holding.
UBS Group first reported a position in Nutrien in Q1 2018 and has held it in 33 quarters since.
UBS Group's Nutrien position peaked at $128M in Q1 2022.
747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.